Global law firm Clifford Chance has advised Paragon Partners (“Paragon)”on its investment in Primed Group, a leading provider of medical devices and sterilization services headquartered in Halberstadt, Germany. As a developer, manufacturer, sterilization service provider and distributor, Primed Group covers the entire value chain and offers an innovative and high-quality product portfolio in the areas of tracheostomy and laryngectomy, wound drainage, thoracic surgery and stool management systems. The transaction closed at the end of October.

The Clifford Chance team led by partner Mark Aschenbrenner and counsel Samuel Frommelt comprised partner Volkmar Bruckner, associates Maja Riedrich, Max Petzelberger (all Private Equity, Munich) and Lorena Loos (Corporate, Milan), counsel Carolin Kemmner and associate Marlene Kießling (both Healthcare, Dusseldorf), partner Dominik Engl and associate Robert Schmidt (both Tax, Frankfurt), partner Stefan Simon and counsel Christopher Fischer (Employment, Frankfurt), counsel Gerson Raiser (Compliance, Frankfurt), senior associates Nicolas Hohn-Hein (IP, Dusseldorf) and Arne Gayk (Antitrust, Dusseldorf) as well as associates Tomáš Procházka and Josef Lysoněk (both Corporate, Prague).

Christian Ritschka and Patricia Backhausen from the Austrian firm Dorda provided advice on Austrian law.